These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19142405)

  • 1. Mild cognitive impairment: cognitive screening or neuropsychological assessment?
    Diniz BS; Nunes PV; Yassuda MS; Pereira FS; Flaks MK; Viola LF; Radanovic M; Abreu ID; Borelli DT; Gattaz WF; Forlenza OV
    Braz J Psychiatry; 2008 Dec; 30(4):316-21. PubMed ID: 19142405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
    Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
    Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil.
    Abreu ID; Nunes PV; Diniz BS; Forlenza OV
    Braz J Psychiatry; 2008 Dec; 30(4):346-9. PubMed ID: 19142410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
    Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
    Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.
    Rasquin SM; Lodder J; Visser PJ; Lousberg R; Verhey FR
    Dement Geriatr Cogn Disord; 2005; 19(2-3):113-9. PubMed ID: 15591801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly.
    Ladeira RB; Diniz BS; Nunes PV; Forlenza OV
    Clinics (Sao Paulo); 2009; 64(10):967-73. PubMed ID: 19841703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
    Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
    Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical memory battery for screening for amnestic mild cognitive impairment in an elderly chinese population.
    Zhao S; Guo C; Wang M; Chen W; Wu Y; Tang W; Zhao Y
    J Clin Neurosci; 2011 Jun; 18(6):774-9. PubMed ID: 21435882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual conversion to alzheimer disease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing.
    Lehrner J; Gufler R; Guttmann G; Maly J; Gleiss A; Auff E; Dal-Bianco P
    Wien Klin Wochenschr; 2005 Sep; 117(18):629-35. PubMed ID: 16416345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-mental State Examination performance in mild cognitive impairment subtypes.
    Diniz BS; Yassuda MS; Nunes PV; Radanovic M; Forlenza OV
    Int Psychogeriatr; 2007 Aug; 19(4):647-56. PubMed ID: 17502007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying amnestic mild cognitive impairment in primary care: a feasibility study.
    Doody RS; Ferris SH; Salloway S; Meuser TM; Murthy AK; Li C; Goldman R
    Clin Drug Investig; 2011; 31(7):483-91. PubMed ID: 21627337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment.
    Forlenza OV; Diniz BS; Talib LL; Radanovic M; Yassuda MS; Ojopi EB; Gattaz WF
    Braz J Psychiatry; 2010 Sep; 32(3):216-22. PubMed ID: 20414590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.